First, in non-small cell lung cancer (NSCLC), miR-19a-3p directly inhibits UBAP2L, resulting in similar phenotypes as those observed upon UBAP2L downregulation, mainly inhibition of cell proliferation, migration and invasion (Pan et al., 2020). This evidence concerns the gene UBAP2L and non-small cell lung carcinoma.